COSCIENS Biopharma Inc. (CSCI)
NASDAQ: CSCI · Real-Time Price · USD
2.981
-0.019 (-0.64%)
Nov 20, 2024, 4:00 PM EST - Market closed

COSCIENS Biopharma Revenue

COSCIENS Biopharma had revenue of $1.87M in the quarter ending September 30, 2024, with 62,266.67% growth. This brings the company's revenue in the last twelve months to $4.83M, down -25.23% year-over-year. In the year 2023, COSCIENS Biopharma had annual revenue of $4.50M, down -20.25%.

Revenue (ttm)
$4.83M
Revenue Growth
-25.23%
P/S Ratio
n/a
Revenue / Employee
$402,833
Employees
12
Market Cap
9.34M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.50M-1.14M-20.25%
Dec 31, 20225.64M380.00K7.22%
Dec 31, 20215.26M1.61M44.03%
Dec 31, 20203.65M3.12M586.47%
Dec 31, 2019532.00K-26.35M-98.02%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ImmunoPrecise Antibodies 17.44M
MSP Recovery 10.73M
Aspira Women's Health 8.92M
QT Imaging Holdings 4.04M
Immuron 3.27M
Exicure 500.00K
Talphera 281.00K
AIM ImmunoTech 190.00K
Revenue Rankings